A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS ® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions
Conditions:   Asthma;   Bioequivalence Interventions:   Drug: Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals;   Drug: FLOVENT DISKUS Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2022 Category: Research Source Type: clinical trials

To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma
Condition:   Bronchial Asthma Interventions:   Drug: Fluticasone propionate Inhalation Aerosol 44 mcg;   Drug: FLOVENT HFA 44 mcg;   Drug: Matching Placebo inhaler Sponsor:   Glenmark Pharmaceuticals Ltd. India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials